Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Dividends Paid - Common (2020 - 2024)

Historic Dividends Paid - Common for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Q4 2024 value amounting to -$78000.0.

  • Maravai Lifesciences Holdings' Dividends Paid - Common changed N/A to -$78000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $494000.0, marking a year-over-year decrease of 1363.64%. This contributed to the annual value of $494000.0 for FY2024, which is 9485.79% down from last year.
  • According to the latest figures from Q4 2024, Maravai Lifesciences Holdings' Dividends Paid - Common is -$78000.0.
  • In the past 5 years, Maravai Lifesciences Holdings' Dividends Paid - Common ranged from a high of $119.7 million in Q4 2020 and a low of -$78000.0 during Q4 2024
  • In the last 5 years, Maravai Lifesciences Holdings' Dividends Paid - Common had a median value of $30.9 million in 2022 and averaged $28.9 million.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Dividends Paid - Common surged by 4096147.54% in 2021, and later tumbled by 9693.58% in 2023.
  • Quarter analysis of 5 years shows Maravai Lifesciences Holdings' Dividends Paid - Common stood at $119.7 million in 2020, then plummeted by 60.61% to $47.2 million in 2021, then plummeted by 34.43% to $30.9 million in 2022, then crashed by 95.78% to $1.3 million in 2023, then tumbled by 105.98% to -$78000.0 in 2024.
  • Its last three reported values are -$78000.0 in Q4 2024, $572000.0 for Q2 2024, and $1.3 million during Q2 2023.